SOURCE: Streetwise Reports

Streetwise Reports

January 28, 2015 13:08 ET

Nobilis Health's President Harry Fleming Interviewed by The Life Sciences Report

SAN FRANCISCO, CA--(Marketwired - Jan 28, 2015) - Nobilis Health Corp. (TSX: NHC) has invented a genuine recipe for success: Provide outpatient surgical services with high profit margins and saturate a local consumer health market with advertising. The company is expected to close out 2014 with around $83 million ($83M) revenue while projecting 2015 revenue at $205M, a 147% increase. In this interview with The Life Sciences Report, Nobilis' president Harry Fleming explains exactly how his booming firm's business model works -- and why investors should take note of the new kid on the block.

The Life Sciences Report: Tell us a little bit about the financial history of Nobilis Health Corp.

Harry Fleming: The company was originally a rollup of ambulatory surgery centers -- outpatient centers. Back in 2007, when it was called Northstar Healthcare Inc., the company successfully launched a high-profile initial public offering (IPO) on the Toronto Stock Exchange for $150M. The IPO was very large for Canada. Dr. Donald Kramer, who is now our chairman, was CEO at the time. In 2010, he got crosswise with the Northstar board of directors and bought a controlling interest to fix some structural issues. The 2010 revenues were $12M. In 2013, revenue rose to $31M. We expect to hit $83M in 2014.

Ambulatory surgery is trending strongly in the U.S. We started out in Texas and Arizona. A recent acquisition has brought Nobilis Health ambulatory surgery centers to eight different states ranging from Minnesota to Florida. We are completing our U.S. registration statement for listing on the New York Stock Exchange...

Continue reading this interview with Harry Fleming: The Outpatient Surgery Business Rains Cash: Nobilis Health's Harry Fleming

About Streetwise Reports - The Life Sciences Report

Investors rely on The Life Sciences Report to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the causes of macro-economic shifts and the strategies that will help you capitalize on these developing trends.

DISCLOSURE:
Nobilis Health Inc. paid The Life Sciences Report to conduct, produce and distribute the interview. Harry Fleming had final approval of the content and is wholly responsible for the validity of the statements. Opinions expressed are the opinions of Harry Fleming and not of The Life Sciences Report or its officers.

Contact Information

  • The Life Sciences Report
    Carrie Beal Amaro
    Email: Email Contact
    Tel: 707-981-8999